Compare GOLF & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GOLF | BLCO |
|---|---|---|
| Founded | 1910 | 1853 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Recreational Games/Products/Toys | Ophthalmic Goods |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 5.9B |
| IPO Year | 2016 | 2022 |
| Metric | GOLF | BLCO |
|---|---|---|
| Price | $85.62 | $16.07 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 7 | 11 |
| Target Price | ★ $83.67 | $18.45 |
| AVG Volume (30 Days) | 320.6K | ★ 464.0K |
| Earning Date | 05-06-2026 | 04-29-2026 |
| Dividend Yield | ★ 1.07% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.36 | N/A |
| Revenue | $1,633,721,000.00 | ★ $5,101,000,000.00 |
| Revenue This Year | $5.76 | $8.65 |
| Revenue Next Year | $2.44 | $5.59 |
| P/E Ratio | $63.16 | ★ N/A |
| Revenue Growth | 4.71 | ★ 6.47 |
| 52 Week Low | $67.14 | $10.99 |
| 52 Week High | $104.81 | $18.92 |
| Indicator | GOLF | BLCO |
|---|---|---|
| Relative Strength Index (RSI) | 36.35 | 48.38 |
| Support Level | $78.60 | $15.36 |
| Resistance Level | $86.07 | $16.61 |
| Average True Range (ATR) | 3.30 | 0.48 |
| MACD | -1.01 | 0.04 |
| Stochastic Oscillator | 11.64 | 71.30 |
Acushnet Holdings Corp is engaged in the design, development, manufacture, and distribution of golf products. Its product category includes golf balls, golf shoes, golf clubs, wedges, putters, golf gloves, golf gear and golf wear, and others. These products are offered through different brands such as Titleist, FootJoy, Scotty Cemeron, Vokey Design, Pinnacle, KJUS, and others. The company's reportable segments are Titleist golf equipment, FootJoy golf wear, and Gofl gear. A majority of its revenue is generated by the Titleist golf equipment segment. Geographically, the company generates maximum revenue from the United States, followed by Europe, Middle East and Asia (EMEA), Japan, Korea, and the Rest of the world.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.